Somnics
1 known investors
Somnics develops iNAP, a mask-free sleep apnea therapy that uses intraoral negative air pressure as an alternative to CPAP, oral appliances, and positional aids. The device is prescribed to obstructive sleep apnea (OSA) patients across Europe, Asia, and the USA.
Digital HealthHardwareHealthtechMedical Devices
Investors · 1
Competitors · 3
by search overlapInspire Medical12 shared keywordsInspire Medical Systems develops an FDA-approved implantable device that treats obstructive sleep apnea (OSA) by working with the patient's natural breathing, controlled via a small remote and intended for patients for whom CPAP is not effective. The device is surgically placed by an ENT and configured by a sleep medicine professional.
Empower Sleep7 shared keywordsEmpower Sleep offers virtual sleep care, connecting patients with sleep doctors for online provider visits, at-home sleep testing, and personalized treatment plans based on continuous sleep tracking data. It serves consumers seeking sleep health support and accepts qualifying insurance plans.
Apnimed7 shared keywordsApnimed develops investigational oral pharmaceutical therapies for obstructive sleep apnea (OSA), including its lead clinical candidate AD109, a neuromuscular approach intended to treat undertreated and untreated OSA patients. It is a clinical-stage pharmaceutical company focused on sleep apnea.
Companies competing with Somnics for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Somnics do?
- Somnics develops iNAP, a mask-free sleep apnea therapy that uses intraoral negative air pressure as an alternative to CPAP, oral appliances, and positional aids. The device is prescribed to obstructive sleep apnea (OSA) patients across Europe, Asia, and the USA.
- Who are Somnics's investors?
- Somnics's investors include TransPacific Venture Partners.